Exonics Therapeutics

Exonics Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1.04B
Latest Deal Amount

Exonics Therapeutics General Information

Description

Developer of gene repair therapies designed for devastating genetic neuromuscular diseases. The company's uses CRISPR/Cas9 technology which is a potential one-time treatment that would make a permanent correction of the mutation that causes Duchenne by identifying and correcting exon mutations that prevent the production of dystrophin, a protein that helps stabilize and protect muscle fibers, enabling patients to improve their lives and have a lifelong benefit.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 490 Arsenal Way
  • Suite 110
  • Watertown, MA 02472
  • United States

Exonics Therapeutics Timeline

20182019
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exonics Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Jul-2019 $1.04B 0000 00.000 Completed Clinical Trials - General
2. Early Stage VC (Series A) 08-Nov-2017 0000 0000 00000 Completed Clinical Trials - General
1. Seed Round 27-Feb-2017 $5M $5M Completed Clinical Trials - General

Exonics Therapeutics Cap Table

To view Exonics Therapeutics‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 000

Exonics Therapeutics Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Calimmune Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000 Venture Capital-Backed Emeryville, CA 00 00000 00000000000 00000
000000 Formerly VC-backed Bannockburn, IL 0000 00000 000000&0 00000
00000000 000000000 Formerly VC-backed Bedford, MA 000 00000 00000000 00000
000000000 00000000 Venture Capital-Backed Salt Lake City, UT 000 00000 000000000 00000

Exonics Therapeutics Former Investors (2)

To view Exonics Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CureDuchenne Ventures Corporate Venture Capital Minority 000 0000 000000 0
The Column Group Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial